A Message from the Chair
A modern medical miracle
I consider stem cells to be a modern medical miracle – the most exciting advance in medicine since antibiotics. Yet just a few years ago, Michigan’s scientists couldn’t make new stem cell lines. Well, they could – but they would be committing a crime that could land them in jail for 10 years and cost them $10 million.
Thankfully, Michigan voters spoke out loudly in favor of curing diseases when in 2008 they approved a constitutional amendment lifting restrictions on stem cell research.
Since then, the progress we have made throughout the state in stem cell research has been nothing short of remarkable. Our great research institutions are hiring new scientists and doing cutting-edge work. The biotech industry is heating up, creating jobs and new opportunities. We’re on the verge of new, life-saving advances in medicine as a result of this burgeoning frontier of research.
At the University of Michigan, the scientists of the Taubman Institute are making incredible progress. Dr. Eva Feldman, our director, is conducting the first human clinical trial of a stem cell treatment for ALS, that terrible condition known as Lou Gehrig's disease. Dr. Max Wicha, a Taubman Scholar and director of the Comprehensive Cancer Center, is leading the first-ever clinical trial targeting cancer stem cells. The Taubman Institute also has established the Consortium for Stem Cell Therapies, one of the few facilities in the nation to produce new embryonic stem cell lines that contain the genetic defects for specific diseases.
I founded the Taubman Institute to support innovative medical science like stem cell research. We are supporting the work of 12 Taubman Scholars, senior physician-scientists working in crucial fields of research such as cancer, cardiovascular disease and neurological disorders. We have also launched an Emerging Scholars Program to foster the careers of promising young physician-scientists.
Yes, it is an exciting time to be in Michigan if you are a medical scientist. We are making crucial laboratory discoveries. More importantly, we’re moving that progress from bench to bedside, where it can help patients suffering from disease. That is the true goal of the Taubman Institute.
Sincerely,
A. Alfred Taubman
Founder and Chair, A. Alfred Taubman Medical Research Institute
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
-
Dr. Eva Feldman discusses stem cell therapies on Michigan Radio
June 14, 2013 -
2013 Taubman Prize
June 05, 2013 -
Stem cell treatment "dramatically slows ALS" in some patients
May 31, 2013
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.




Donors pitch in to keep brilliant science minds at U-M Video